Company / Working Capital per Share
Zivo Bioscience, Inc. Working Capital per Share History
FY2013-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$0.17
FY2024
5-year range
-$1.49 / $1.16
FY2020-FY2024
Trend
+88.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share returned to growth in FY2024 after 2 years of decline, reaching $-0.17.
Based on SEC 10-K filings.
-0.17 in FY2024.
Declined from $-0.01 to $-0.17 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, working capital per share increased 88.5% year-over-year.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -96.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.17 | +88.5% |
| FY2023 | -$1.49 | -11020.9% |
| FY2022 | -$0.01 | -101.1% |
| FY2021 | $1.16 | +4384.3% |
| FY2020 | -$0.03 | +41.3% |
| FY2019 | -$0.05 | +42.6% |
| FY2016 | -$0.08 | -110.2% |
| FY2015 | -$0.04 | +27.7% |
| FY2014 | -$0.05 | +45.1% |
| FY2013 | -$0.10 | -195.9% |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026